Stock Worth Watching: Mead Johnson Nutrition Co (NYSE:MJN) Institutional Investors Sentiment Index Dive in Q2 2016

November 25, 2016 - By Dolores Ford   ·   0 Comments

Stock Worth Watching: Mead Johnson Nutrition Co (NYSE:MJN) Institutional Investors Sentiment Index  Dive in  Q2 2016

Sentiment for Mead Johnson Nutrition Co (NYSE:MJN)

Mead Johnson Nutrition Co (NYSE:MJN) institutional sentiment increased to 0.83 in Q2 2016. Its up 0.11, from 0.72 in 2016Q1. The ratio has increased, as 190 funds started new or increased stock positions, while 264 reduced and sold equity positions in Mead Johnson Nutrition Co. The funds in our partner’s database reported: 174.74 million shares, down from 181.11 million shares in 2016Q1. Also, the number of funds holding Mead Johnson Nutrition Co in their top 10 stock positions was flat from 10 to 10 for the same number . Sold All: 44 Reduced: 220 Increased: 153 New Position: 37.

Mead Johnson Nutrition Company is a pediatric nutrition company. The company has a market cap of $13.44 billion. The Firm makes, distributes and sells infant formulas, children’s nutrition and other nutritional products. It has a 26.98 P/E ratio. The Firm operates through three divisions: Asia, North America/Europe and Latin America.

The stock increased 0.28% or $0.2 during the last trading session, hitting $72.59. About 428,624 shares traded hands. Mead Johnson Nutrition CO (NYSE:MJN) has declined 13.72% since April 22, 2016 and is downtrending. It has underperformed by 19.13% the S&P500.

Analysts await Mead Johnson Nutrition CO (NYSE:MJN) to report earnings on January, 26. They expect $0.84 earnings per share, up 7.69% or $0.06 from last year’s $0.78 per share. MJN’s profit will be $155.53 million for 21.60 P/E if the $0.84 EPS becomes a reality. After $0.87 actual earnings per share reported by Mead Johnson Nutrition CO for the previous quarter, Wall Street now forecasts -3.45% negative EPS growth.

According to Zacks Investment Research, “Mead Johnson, a global leader in pediatric nutrition, develops, manufactures, markets and distributes more than 70 products in over 50 markets worldwide. The company’s mission is to nourish the world’s children for the best start in life. The Mead Johnson name has been associated with science-based pediatric nutrition products for over 100 years. The company’s Enfa family of brands, including Enfamil® infant formula, is the world’s leading brand franchise in pediatric nutrition.”

Vgi Partners Pty Ltd holds 14.77% of its portfolio in Mead Johnson Nutrition CO for 561,590 shares. Emerging Sovereign Group Llc owns 1.46 million shares or 9.09% of their US portfolio. Moreover, Holowesko Partners Ltd. has 8.41% invested in the company for 1.10 million shares. The California-based Blue Jay Capital Management Llc has invested 8.05% in the stock. Boussard & Gavaudan Investment Management Llp, a United Kingdom-based fund reported 262,858 shares.#img1#

Insider Transactions: Since January 1, 0001, the stock had 0 insider buys, and 3 selling transactions for $4.13 million net activity.

Mead Johnson Nutrition CO (NYSE:MJN) Ratings Coverage

Ratings analysis reveals 14% of Mead Johnson Nutrition Company’s analysts are positive. Out of 14 Wall Street analysts rating Mead Johnson Nutrition Company, 2 give it “Buy”, 2 “Sell” rating, while 10 recommend “Hold”. The lowest target is $75 while the high is $100. The stock’s average target of $89.17 is 22.84% above today’s ($72.59) share price. MJN was included in 25 notes of analysts from September 16, 2015. The firm earned “Market Perform” rating on Thursday, October 15 by BMO Capital Markets. The stock has “Underperform” rating given by CLSA on Friday, January 8. JP Morgan downgraded the shares of MJN in a report on Monday, January 11 to “Neutral” rating. The firm has “Hold” rating by Zacks given on Thursday, September 17. The rating was maintained by Credit Suisse on Tuesday, January 19 with “Neutral”. The rating was upgraded by Bank of America on Wednesday, July 13 to “Neutral”. The company was downgraded on Thursday, October 8 by Bank of America. As per Tuesday, July 26, the company rating was upgraded by JP Morgan. The rating was downgraded by Goldman Sachs to “Neutral” on Monday, December 14. As per Friday, October 23, the company rating was downgraded by Credit Suisse.

MJN Company Profile

Mead Johnson Nutrition Company (Mead Johnson), incorporated on December 17, 2008, is a pediatric nutrition company. The Firm makes, distributes and sells infant formulas, children’s nutrition and other nutritional products. The Firm operates through three divisions: Asia, North America/Europe and Latin America. The Company’s product portfolio includes routine and specialty infant formulas, children’s milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders. The Company’s Enfa family of brands, including Enfamil infant formula, is a brand franchise in pediatric nutrition. The Company’s product portfolio addresses a range of nutritional needs for infants, children and expectant and nursing mothers. The Firm markets its portfolio of approximately 70 products to mothers, healthcare professionals and retailers in over 50 countries in Asia, North America, Latin America and Europe.

More news for Mead Johnson Nutrition CO (NYSE:MJN) were recently published by: Forbes.com, which released: “Mead Johnson Nutrition Enters Oversold Territory (MJN)” on September 16, 2016. Seekingalpha.com‘s article titled: “Finding Value In Consumer Staples: Mead Johnson Nutrition” and published on November 12, 2016 is yet another important article.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Dolores Ford


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>